TOI ONCOLOGY INSTITUTE INC (THE)

The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference

The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference

CERRITOS, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the 25th Annual Needham Healthcare Conference, being held virtually on Wednesday, April 15, 2026, including a fireside chat at 3:45 p.m. ET.

A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at .

About The Oncology Institute ():

Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.

Media

The Oncology Institute, Inc.





Investors

ICR Healthcare



EN
09/04/2026

Underlying

TOIONCOLOGY INSTITUTE INC (THE)

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ONCOLOGY INSTITUTE INC (THE)

Jonathan Moreland
  • Jonathan Moreland
Free Trial
MKC McCormick & Com...
CTAS Cintas Corporat... ... (+15)

InsiderInsights.com Daily Ratings Report: April 13, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

MKC MCCORMICK & COMPANY INCORPORATED
CTAS CINTAS CORPORATION
BZUN BAOZUN INC SPONSORED ADR CLASS A
NMM NAVIOS MARITIME PARTNERS
SPT SPROUT SOCIAL
DNA INC.
TOI GINKGO BIOWORKS HOLDINGS
SMR INC.
GF ONCOLOGY INSTITUTE INC (THE)
MESO NUSCALE POWER CORP
COE THE NEW GERMANY FUND
INC.
MESOBLAST LIMITED
COLUMBIA EQUITY TRUST
INC.
04/14/26 April 14, 2026 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute Achieves $1.8 Million in Medicare Savings in CM...

The Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period Improvement Practice earns maximum quality scores on avoidable ED visits and admissions for second consecutive period; per-episode savings exceed $6,400 CERRITOS, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, achieved $1.8 million in Medicare savings during Performance Period 3 of the Centers for Medicare & Medicaid Services’ Enhancin...

April 13, 2026 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
AYI Acuity Brands ...
SSNC SS&C Technologi... ... (+46)

InsiderInsights Weekly Report: April 11, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

AYI ACUITY BRANDS INC.
SSNC SS&C TECHNOLOGIES HOLDINGS INC.
GSBD GOLDMAN SACHS BDC INC
FMNB FARMERS NATIONAL BANC CORP.
BZUN BAOZUN INC SPONSORED ADR CLASS A
CULP CULP INC.
SCVL SHOE CARNIVAL INC.
WVE WAVE LIFE SCIENCES
TSI TCW STRATEGIC INCOME FUND INC.
CIA CITIZENS INC. CL A
FUL H.B. FULLER COMPANY
CRT CROSS TIMBERS ROYALTY TRUST
LW LAMB WESTON HOLDINGS INC.
VALE. COMPANHIA VALE DO RIO DOCE CEDEAR
NKE NIKE INC. CLASS B
PAGS PAGSEGURO DIGITAL LTD
FUND ROYCE FOCUS TRUST
FGBI INC.
NMM FIRST GUARANTY BANCSHARES
RPAY NAVIOS MARITIME PARTNERS
GO REPAY HOLDINGS (A)
SVC GROCERY OUTLET HOLDING
AHCO SERVICE PROPERTIES TRUST
AIMD.P ADAPTHEALTH
CNXC AIM4 VENTURES
QFIN CONCENTRIX
VSCO 360 DIGITECH INC
SG VICTORIA'S SECRET & CO
TOI SWEETGREEN INC
IPX ONCOLOGY INSTITUTE INC (THE)
HDB IPERIONX LTD
TSM HDFC BANK LTD
IBRX TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
ECAT IMMUNITYBIO INC
POCI BLACKROCK ESG CAP ALLOCATION TR
BPRN PRECISION OPTICS CORP INC (MASS)
LPCN BANK OF PRINCETON
GAM LIPOCINE INC
HYMC GENERAL DE ALQUILER DE MAQUINARIA
BETR HYCROFT MINING HOLDING CORPORATION
VERO BETTER HOME & FINANCE HOLDING COMPANY
BNR VENUS CONCEPT INC
VVOS BURNING ROCK BIOTECH LIMITED
MESO VIVOS THERAPEUTICS INC
USAU MESOBLAST LIMITED
USA URANIUM
04/13/26 April 13, 2026 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute to Participate in the 25th Annual Needham Healt...

The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference CERRITOS, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the 25th Annual Needham Healthcare Conference, being held virtually on Wednesday, April 15, 2026, including a fireside chat at 3:45 p.m. ET. A webcast link of the presentation will be accessible through the Investo...

April 9, 2026 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute Names Minh Merchant Chief Legal Officer

The Oncology Institute Names Minh Merchant Chief Legal Officer CERRITOS, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Minh Merchant has joined the organization as Chief Legal Officer. In this role, Ms. Merchant will oversee legal, regulatory, compliance and privacy functions as TOI continues to scale. This role will be essential in enabling the company to continue its growth trajectory while further enhancing its mission to be a trusted healthcare par...

April 6, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch